Quality specifications for clinical chemical analyses used to monitor patients with diabetes mellitus

C Berne¹

Affiliations

C Berne. Ups J Med Sci. 1990.

. 1990;95(3):191-6.

doi: 10.3109/03009739009178589.

C Berne¹

No abstract available

Similar articles

NIST's role in measurement accuracy for diagnosis and monitoring of diabetes.
Welch MJ; National Institute of Standards and Technology (NIST). Welch MJ, et al. Diabetes Technol Ther. 2002;4(1):77-9. doi: 10.1089/15209150252924120. Diabetes Technol Ther. 2002. PMID: 12017424 No abstract available.
Quality specifications for haemoglobin A1c assays in the monitoring of diabetes.
Larsen ML, Petersen PH, Fraser CG. Larsen ML, et al. Ups J Med Sci. 1993;98(3):335-8. doi: 10.3109/03009739309179329. Ups J Med Sci. 1993. PMID: 7974864 No abstract available.
Standardization, calibration, and the care of diabetic patients.
Bruns DE. Bruns DE. Clin Chem. 1992 Dec;38(12):2363-4. Clin Chem. 1992. PMID: 1458568 No abstract available.
The economic burden of diabetes and the benefits of improved glycemic control: the potential role of a continuous glucose monitoring system.
Skyler JS. Skyler JS. Diabetes Technol Ther. 2000;2 Suppl 1:S7-12. doi: 10.1089/15209150050214069. Diabetes Technol Ther. 2000. PMID: 11469636 Review. No abstract available.
Managing diabetes in hospitalized patients with chronic kidney disease.
Iyer SN, Tanenberg RJ. Iyer SN, et al. Cleve Clin J Med. 2016 Apr;83(4):301-10. doi: 10.3949/ccjm.83a.14189. Cleve Clin J Med. 2016. PMID: 27055204 Review.